Showing results (111-120 of 156) with videos related to
Sort By:
Pageof 16
Future Oncology (London, England)|September 17, 2020
Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumabMurtuza Bharmal, Sandra Nolte, Céleste Lebbé, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2023
Stereotactic body radiation therapy for sarcoma pulmonary metastasesEmily S Lebow, Stephanie M Lobaugh, Zhigang Zhang, et al.The Lancet. Oncology|September 6, 2016
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trialHoward L Kaufman, Jeffery Russell, Omid Hamid, et al.JCO Precision Oncology|December 7, 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway GenesEvan Rosenbaum, Philip Jonsson, Kenneth Seier, et al.Investigational New Drugs|August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumorCiara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2025
Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell LiposarcomaSandra P D'Angelo, Mihaela Druta, Brian A Van Tine, et al.Cancer Immunology Research|March 2, 2016
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1Jarushka Naidoo, Katja Schindler, Christiane Querfeld, et al.European Journal of Cancer (Oxford, England : 1990)|November 8, 2020
Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumourPhilippe A Cassier, Antoine Italiano, Carlos Gomez-Roca, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2016
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus IpilimumabSandra P D'Angelo, Alexander N Shoushtari, Mary Louise Keohan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced SarcomaMrinal M Gounder, Evan Rosenbaum, Nian Wu, et al.Pageof 16